Key result
2025 U.S. hypertension guidelines recommend lower BP targets, out-of-office monitoring, and new resistant hypertension therapies.
Why the study?
Updated U.S. and international hypertension guidelines reflect new studies and analyses that support changes in hypertension management.
Updated 2025 U.S. hypertension guidelines emphasize lower blood pressure targets and out-of-office monitoring to improve cardiovascular and cognitive outcomes.
Supports lower BP targets and out-of-office monitoring in hypertension; extends prior guidelines with new evidence.
Updated U.S. and international hypertension guidelines reflect new studies and analyses that support changes in hypertension management. The 2025 U.S. guideline for prevention, detection, evaluation, and management of high blood pressure (BP) recommends lower BP targets, greater use of out-of-office BP for diagnosis and medication titration, and a different approach to severe hypertension presenting without acute or evolving cardiovascular disease symptoms or signs. New treatments for resistant hypertension are recommended. Trial evidence supports benefit from tighter BP control to prevent mild cognitive impairment and dementia, further emphasizing the importance of lower BP goals.
No takes yet. Share an insight, caveat, or question.
Sandra J. Taler (2026) conducted a review in Hypertension. Updated hypertension guidelines was evaluated. The 2025 U.S. hypertension guidelines recommend lower blood pressure targets, greater use of out-of-office blood pressure monitoring, and new treatments for resistant hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: